1 |
National Cancer Information Center. National cancer statistics 2014 [Internet].Gyeonggi:National Cancer Information Center; 2014 [cited 2017 January 5]. Available from: l.mbs/cancer/subview.jsp?id=cancer.
|
2 |
Grunfeld EA, Hunter MS, Sikka P, Mittal S. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Education Counseling. 2005;59(1):97-102.
DOI
|
3 |
Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric. 2006;9(1):49-58.
DOI
|
4 |
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1(3):385-401.
DOI
|
5 |
Cho MJ, Nam JJ, Suh GH. Prevalence of symptoms of depression in a nationwide sample of Korean adults. Psychiatry Research. 1998;81(3):341-352.
DOI
|
6 |
Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clinical Therapeutics. 2007;29(2):230-241.
DOI
|
7 |
Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. Journal of the National Cancer Institute. 2000;92(13):1054-1064.
DOI
|
8 |
Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric co-morbidity and management. International Journal of Methods in Psychiatric Research. 2003;12(1):34-43.
DOI
|
9 |
Cluze C, Rey D, Huiart L, BenDiane MK, Bouhnik AD, Berenger C, et al. Adjuvant endocrine therapywith tamoxifen in young women with breast cancer: determinants of interruptions vary over time. Annals of Oncology. 2012;23(4):882-890.
DOI
|
10 |
Gotay C, Dunn J. Adherence to long-termadjuvant hormonal therapy for breast cancer. Expert Reviewof Pharmacoeconomics & Outcomes Research. 2011;11(6):709-715. http://dx.doi.org/10.1586/erp.11.80
|
11 |
Hwang E, Yi M. Factors influencing quality of life in patients with breast cancer on hormone therapy. Journal of Korean Academy of Nursing. 2014;44(1):108-117. http://dx.doi.org /10.4040/jkan.2014.44.1.108
DOI
|
12 |
Korean Breast Cancer Society. The breast. 2nd ed. Seoul: Ilchokak Publishing Co; 2005.
|
13 |
Dorjgochoo T, Gu K, Kallianpur A, Zheng Y, Zheng W, Chen Z, et al. Menopausal symptoms among breast cancer patients 6 months after cancer diagnosis: a report from the Shanghai Breast Cancer Survival Study(SBCSS). Menopause. 2009;16(6):1205-1212.
DOI
|
14 |
Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. European Journal of Cancer. 2005;41(17):2613-2619.
DOI
|
15 |
Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA. Prevalence and treatment of menopausal symptoms among breast cancer survivors. Journal of pain and symptom management. 2002;23(6):501-509.
DOI
|
16 |
Korean Breast Cancer Society. Breast Cancer Facts & Figures 2016. Seoul: Korean Breast Cancer Society, 2016. p. 1-21.
|
17 |
Ganz PA. Breast cancer, menopause, and long-termsurvivorship: critical issues for the 21st century. The American Journal of Medicine. 2005;118(12):136-141.
DOI
|
18 |
Cappiello M, Cunningham RS, Knobf MT, Erdos D. Breast cancer survivors information and support after treatment. Clinical Nursing Research. 2007;16(4):278-293.
DOI
|
19 |
Luber MP, Meyers BS, Williams-Russo PG, Hollenberg JP, DiDomenico TN, Charlson ME, et al. Depression and service utilization in elderly primary care patients. The American Journal of Geriatric Psychiatry. 2001;9(2):169-176.
DOI
|
20 |
Fontaine C, Meulemans A, Huizing M, Collen C, Kaufman L, DeMey J, et al. Tolerance of adjuvant letrozole outside of clinical trials. The Breast. 2008;17(4):376-381.
DOI
|
21 |
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology. 2000;18(4):743-753.
DOI
|
22 |
Mausbach BT, Schwab RB, Irwin SA. Depression as a predictor of adherence to adjuvant endocrine therapy(AET) in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment. 2015;152(2):239-246. http://dx.doi.org/10.1007/s10549-015-3471-7
DOI
|
23 |
Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24(5):583-590.
DOI
|
24 |
Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: conceptual, design, measurement, and analysis issues. Journal of Pain and Symptom Management. 2006;31(1):85-95.
DOI
|
25 |
Byar KL, Berger AM, Bakken SL, Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncology Nursing Forum; 2006;33(1):18-26.
DOI
|
26 |
Avis NE, Crawford S, Manuel J. Psychosocial problems among younger women with breast cancer. Psycho-Oncology. 2004;13(5):295-308.
DOI
|
27 |
Yang YH. Trajectory of fatigue, quality of life and physical symptoms in cancer patients receiving radiotherapy. Journal of Korean Academy of Nursing. 2003;33(5):562-569.
DOI
|
28 |
Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA. The Menopause rating scale(MRS) scale: a methodological review. Health and quality of life Outcomes. 2004;2(1):1-8.
DOI
|
29 |
Vahdaninia M, Omidvari S, Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Social Psychiatry and Psychiatric Epidemiology. 2010;45(3):355-361. http://dx.doi.org/10.1007/s00127-009-0068-7
DOI
|
30 |
Moon JM. Menopause symptoms, fatigue, and quality of life in post-chemotherapy breast cancer survivors [dissertation]. Seoul: Yonsei University. 2009. p. 1-108.
|